Instituto Genesis West-Provida (1994)

Click here for the report

Covalent Silver has an anti-parasitic condition property in vivo and in vitro. Target cells decreased in number during the study. This parasitic condition not only decreased after the first dose, but also eventually disappeared. The parasitic condition corresponded to the Somatid Cycle, where it was seen to reverse from a pathogenic to a non-pathogenic cycle. Covalent Silver has no effect on red blood cells. The presence of parasitic forms in the plasma and bacterial activity presented the patient on arrival was (+++) which, after the first dose, decreased to (+) and then decreased to 0. This means a decrease and then a complete elimination of the parasitic condition. Target cells were seen with (+++) in the second sample taken and decreased to (+). The presence of pathogenic Somatids at the beginning of the study varied from rod to mycelial and asci forms. These were corrected by the second dose of Covalent Silver. It is important to record the patient was completing a course of antibiotics. However, there is no relationship between the diminishing of pathogenic forms and the use of antibiotics, but there is a decrease when 714x is used. In this case the patient had already started the 714x program. 714x typically shows changes within the first 21-day cycle. The amount of nonpathogenic Somatids was zero at the beginning, and starting to increase with the presence of the double spores that were in the limit of becoming pathogenic, just prior to the second dose. This pattern was stable until the end of the study. Further investigations must be made.

The yeast/fungus was present at all times in large amounts (+++), with pathogenic forms. The pathogenicity was determined by the presence of large colonies five minutes after taking the blood sample. These differed from the results of the invitro samples, where all the fungus was phagocytised, as previously discussed. The presence of fungus is related to the pH of the plasma, nutrition habits, and immune system activity. The cellular immune system activity was low as was the white cell proportion, with a predominance of neutrophils and eosinophils in the first reading. This slowly improved starting with better proportions of white cells and continuing with better activity. This level of activity was sustained until the end of the study. This corresponds to the in vitro analysis. It can therefore be assumed that there is an immune stimulating response action from Covalent Silver both in the in-vitro and in-vivo experiment. During the study with Covalent Silver there was a decrease in liver stress. This was seen by a reduction of the fibrin spicules. The patient did not receive any liver protectors, therefore Covalent Silver has a liver protector effect. The high cholesterol observed in the beginning of the study showed a sudden decrease immediately after the second dose of Covalent Silver, from (+++) to (+) in a period of less than a month.